ReviewCancer treatment reviews2018

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.

Ryuma Tokunaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.